Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2024 Feb 27;4(2):e0002250. doi: 10.1371/journal.pgph.0002250

Understanding COVID-19 vaccine hesitancy in Meghalaya, India: Multiple correspondence and agglomerative hierarchical cluster analyses

Sooyoung Kim 1,#, Rajiv Sarkar 2,#, Sampath Kumar 3, Melissa Glenda Lewis 2, Yesim Tozan 4,*, Sandra Albert 2,*
Editor: Nnodimele Onuigbo Atulomah5
PMCID: PMC10898751  PMID: 38412201

Abstract

Meghalaya, a state in the northeastern region of India, had a markedly low vaccine uptake compared to the other states in the country when COVID-19 vaccines were being rolled out in 2021. This study aimed to characterize the distinct vaccine-hesitant subpopulations in healthcare and community settings in Meghalaya state in the early days of the vaccination program. We used data from a cross-sectional survey that was administered to 200 healthcare workers (HCWs) and 200 community members, who were a priori identified as ‘vaccine-eligible’ and ‘vaccine-hesitant,’ in Shillong city, Meghalaya, in May 2021. The questionnaire collected information on participants’ sociodemographic characteristics, COVID-19 history, and presence of medical comorbidities. Participants were also asked to provide a dichotomous answer to a set of 19 questions, probing the reasons for their hesitancy towards COVID-19 vaccines. A multiple correspondence analysis, followed by an agglomerative hierarchical cluster analysis, was performed to identify the distinct clusters of vaccine-hesitant participants. We identified seven clusters: indecisive HCWs (n = 71), HCWs skeptical of COVID-19 and COVID-19 vaccines (n = 128), highly educated male tribal/clan leaders concerned about infertility and future pregnancies (n = 14), less educated adults influenced by leaders and family (n = 47), older adults worried about vaccine safety (n = 76), middle-aged adults without young children (n = 56), and highly educated ethnic/religious minorities with misinformation (n = 8). Across all the clusters, perceived logistical challenges associated with receiving the vaccine was identified as a common factor contributing to vaccine hesitancy. Our study findings provide valuable insights for local and state health authorities to effectively target distinct subgroups of vaccine-hesitant populations with tailored health messaging, and also call for a comprehensive approach to address the common drivers of vaccine hesitancy in communities with low vaccination rates.

Introduction

Since the World Health Organization (WHO) declared COVID-19 as a pandemic in March 2020, it has affected various aspects of people’s lives across the globe [1]. In India, a country with significant within-country disparities in health and socioeconomic conditions, the impact of COVID-19 pandemic was the most pronounced during its second wave, which started around late March 2021. The introduction of the Delta variant marked the country as one of the global epicenters [2,3]. Just before this surge in cases, the national COVID-19 vaccination roll-out began in January 2021 with healthcare and frontline workers given priority. By April 1, 2021, the priority gradually expanded to include any residents of age 45 years and older, while others could still receive the vaccine with an out-of-pocket co-pay [4]. From May 1, 2021, eligibility was expanded to all adults aged 18 years and above [5]. The COVID-19 vaccination program in India has been decentralized, with each state government being responsible for vaccine distribution [6]. During this period, there were significant regional disparities in both COVID-19 infection and vaccination rates. In general, COVID-19 infections were highly clustered in more urbanized and prosperous states [79], and so was the distribution of COVID-19 vaccines [10]. These within-country disparities were due to a myriad of factors, including population density, healthcare infrastructure, socioeconomic status, mobility, and supply chain issues, all of which collectively shaped the differential impacts of the pandemic across different regions [710]. On the other hand, several studies highlighted the disparities in the quality of COVID-19 data reporting, which hindered an accurate estimation of the disease burden of COVID-19 and other associated issues, including an adequate understanding of the extent of vaccine hesitancy and refusal, in less prosperous states [11,12]. The national vaccination registration page, which was available only in English, and the COVID-19 vaccination co-pay at private health facilities, which could be up to $20 per dose, also exacerbated the disparities across the country [13].

Meghalaya, a state in the northeastern region of India, has a population of around 3.44 million people and home to a large number of tribal communities, whose ethnicities are Khasi, Jaintia, and Garo tribes [14,15]. As of 2021, Meghalaya was the fifth poorest state in India with a predominantly agrarian economy [16]. Even before the COVID-19 pandemic, Meghalaya had low immunization rates for routine childhood vaccines [17]. This had been identified as an issue by the state, and Meghalaya implemented a dedicated intervention based on the principles of a state capability approach in 2020 to mobilize all the stakeholders from the state’s leadership to frontline healthcare workers to communities, which led to rapid improvements in vaccination coverage [18]. Nonetheless, in the beginning of the COVID-19 vaccine roll-out in 2021, Meghalaya was one of the lowest-performing states in India with its COVID-19 vaccine coverage ranking 26th out of the 28 states and nine union territories [10].

In early May 2021, at a COVID-19 expert committee meeting of the state government of Meghalaya, anecdotes of high vaccine hesitancy among workers at various tertiary care hospitals in the capital city of Shillong, Meghalaya, were brought up and discussed. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) Working Group defines vaccine hesitancy as “delay in acceptance or refusal of vaccination despite availability of vaccination services.” [19] At the time, several studies documented high rates of COVID-19 vaccine hesitancy among healthcare workers in different parts of the world [2024] This was particularly concerning given the crucial role of healthcare workers in promoting vaccine acceptance among vaccine-hesitant communities [25]. The evidence on the nature and extent of COVID-19 vaccine hesitancy among healthcare workers in India is limited but has been growing [26]. However, no study has focused on north-east India, including Meghalaya state, where routine vaccination rates in the general population are markedly low. Furthermore, the characteristics of vaccine-hesitant groups in this particular setting have not been described, which are known to be vaccine- and context-specific and vary across populations and over time [19].

Against this background, our study aimed to identify the distinct subgroups of vaccine-hesitant populations in the healthcare and community settings in Meghalaya state during the early days of the COVID-19 vaccination program. The overall goal of this study was to contribute to the scant evidence that can guide public health authorities in developing appropriate interventions to address the issue of vaccine hesitancy in communities with low vaccination coverage. The issue of vaccine hesitancy has become more evident during a global pandemic and in the face of new and novel vaccines to address it. Existing studies have shown that vaccine hesitancy is associated with individuals’ socioeconomic status, which can be reflected in individuals’ health-related knowledge, attitudes, and beliefs in general [27,28]. Furthermore, individuals’ perceived barriers and negative attitudes toward vaccination may exert unique effects on their acceptance of vaccines [29]. Under this notion, we aimed to examine the factors that might have affected COVID-19 vaccine acceptance in a setting with low overall vaccination rates, with the primary aim of identifying the distinct clusters of individuals who can be potentially targeted with tailored communication strategies. Our findings also have implications for designing targeted strategies to improve vaccination compliance among healthcare workers.

Methods

Ethics statement

The protocol for this study was approved by the Indian Institute of Public Health Shillong Institutional Ethics Committee (IIPHS IEC) in April 2021 (Reference no: IIPHS-IEC/2021-22/01). Written consent was obtained from health workers who participated in face-to-face interviews, and verbal consent was sought from community members who were interviewed via phone due to the COVID-19 lockdown. Additional information regarding the ethical, cultural, and scientific considerations specific to inclusivity in global research is included in the (S1 Checklist).

Study sample and data collection

This mixed-method study, comprising of a cross-sectional survey and qualitative key-informant interviews, was conducted in May 2021 to investigate the drivers of COVID-19 vaccine hesitancy among healthcare workers and members of the wider community in Shillong city, Meghalaya, India. The cross-sectional survey was conducted among people who were a priori identified as potentially ‘vaccine-hesitant’ [20,30,31]. Based on the WHO SAGE definition of vaccine hesitancy [19], for both groups, a vaccine-hesitant individual was defined as “an individual who did not receive COVID-19 vaccination by April 15, 2021 despite having had an opportunity to receive it free of charge.” By this date, COVID-19 vaccines were available to healthcare workers and other frontline workers, as well as to anyone aged 45 years and above at no cost, while the rest of the population had to co-pay to receive the vaccine. For this reason, we limited our community sample to those aged 45 years and above. The healthcare workers were recruited from four tertiary care hospitals, including the two largest state government-run hospitals and two private multispecialty hospitals in Shillong city. The second group included vaccine-hesitant members of the wider community, residing in hotspots with low COVID-19 vaccination coverage in East Kasi Hill district in Shillong city. A stratified random sampling was conducted among eligible healthcare workers using the occupation categories within the health sector (i.e., doctor, nurse, paramedical staff, frontline worker, and support staff). For community members, a list of localities in Shillong agglomeration with their respective estimated population size and COVID-19 vaccine coverage rate was obtained from the local health authorities. Using this list, a total of 10 clusters with a reported vaccination coverage rate of less than 40% were selected using a probability-proportion-to-size (PPS) approach. We then recruited participants using a random sampling approach from the list of eligible individuals provided by the Accredited Social Health Activists (ASHAs) in each cluster. ASHAs are government-employed community based frontline health workers who form a key component of the National Health Mission (NHM) in India [32]. Informed consent was obtained from all participants prior to the survey administration and those who did not express their consent were excluded from the survey. Written consent was obtained from health workers who participated in face-to-face interviews, and verbal consent was sought from community members who were interviewed via phone due to the COVID-19 lockdown. The recruitment of participants took place between May 1st, 2021 and May 22th, 2021.

The questionnaire was administered to healthcare workers face-to-face in English by trained bilingual research staff. For community members, telephonic interviews were conducted due to travel restrictions imposed during the ‘lockdown’ related to the ongoing pandemic. The telephone numbers of all residents in the selected localities were obtained from the ASHAs. Potential eligible participants were randomly selected and contacted for the survey. After obtaining informed consent and ascertaining their vaccination status, interviews were conducted in the local Khasi language by trained volunteers. The questionnaire collected information on participants’ sociodemographic characteristics, including age, gender, ethnicity, religion, occupation, educational attainment, and place of residence, and COVID-19 history, and presence of medical comorbidities. Participants were also asked to provide a dichotomous (yes or no) answer to a set of 19 questions (Table A in S1 Text), probing perceived barriers and negative attitudes toward COVID-19 vaccination which may influence COVID-19 vaccine acceptance among vaccine hesitant populations. Unstructured responses to describe their reasons for vaccine hesitancy were also recorded.

Statistical analysis

We first performed a descriptive analysis to characterize the participants’ demographic and socioeconomic characteristics. Using a R package wordcloud [33], we performed an exploratory textual analysis to investigate the stated reasons for vaccine hesitancy captured in the unstructured responses. We then performed a multiple correspondence analysis (MCA) followed by an agglomerative hierarchical cluster analysis (AHCA) to identify the unique clusters of vaccine-hesitant survey participants. We employed these explanatory analytical techniques because these techniques are well suited to analyze the pattern of relationships in a data set of multiple categorical variables. When combined, these methods can effectively capture the complex patterns in a dataset through dimensionality reduction and find clusters in a data set. Specifically, the MCA can be described as a type of principal component analysis (PCA) of categorical data [34]. In this analogy, a dataset of n observations and m variables is considered as a n x m matrix in a high-dimensional Euclidean space, and the MCA aims to reduce the dimensions of the space while capturing the most variance in the data [34]. To do so, the technique combines correlated categorical variables in the data set into continuous variables. To run the MCA, we first recoded the continuous age variable as a categorical age group variable using a 5-year step increment. In the MCA, we included participants’ sociodemographic characteristics (i.e., age, gender, ethnicity, religion, occupation, and educational attainment), COVID-19 history, whether the participant had any medical comorbidity, whether the participant had any child, whether the participant’s child received essential childhood immunizations and participants’ responses to the 19 questions, probing their perceived barriers and negative attitudes for COVID-19 vaccination.

Subsequently, the continuous variables that resulted from the MCA were grouped using hierarchical clustering analysis, which employs a step-wide approach to classify individual observations into clusters based on the measure of similarity or distance [35,36]. There are two types of hierarchical clustering: agglomerative (bottom-up) clustering and divisive (top-down) clustering. Agglomerative clustering can be further divided into subtypes based on the clustering algorithm. In this analysis, we performed the clustering using five different clustering methods, namely arithmetic average-based agglomerative clustering, single linkage agglomerative clustering, complete linkage agglomerative clustering, Ward’s agglomerative clustering, and divisive clustering. We then used the clustering coefficients from each clustering output as a criterion to determine the best clustering method to interpret the outputs. The clustering coefficient, which ranges between 0–1, describes the strength of the generated clustering structure, and values closer to 1 indicate a stronger clustering structure. Lastly, we used the sum of within-cluster inertia, calculated as a clustering output, to determine the optimal number of clusters. Specifically, the partition was determined at the point with the highest relative loss of inertia [37]. All analyses were performed using R packages FactoMineR, cluster, and factoextra on R version 4.2.2. [3840] Study data is available as a supporting information (S1 Data) with PLOS Human Participants Research Checklist.

Results

Sample description

Table 1 presents the sociodemographic characteristics of the survey participants. Of the 400 participants, 200 were healthcare workers, and 200 were community members. The survey participants were predominantly female; 70.0% of community members and 80.0% of healthcare workers. The majority of participants identified themselves as Khasi (89.0%) and Christians (90.5%). A little over half of healthcare workers (51.0%) had a college degree or higher, and 74.0% of community members had an educational attainment below college level, with more than one third (37.5%) having completed up to grade 7, which is equivalent to less than a high school diploma. The participants from the wider community were primarily concentrated in two blocks in East Khasi Hills district, with 41.5% residing in Mawlai block and 37.5% in Mylliem block. Among healthcare workers, the majority identified themselves as nurses (40.5%), followed by frontline workers (14.0%), paramedic staff (16.5%), and support staff (24.5%).

Table 1. Sociodemographic characteristics of the survey participants (N = 400).

Community members
(N = 200)
Healthcare workers
(N = 200)
Total
(N = 400)
Age
    Mean (SD) 56.3 (8.74) 34.3 (8.69) 45.3 (14.0)
Sex
    Male 79 (39.5%) 41 (20.5%) 120 (30.0%)
    Female 121 (60.5%) 159 (79.5%) 280 (70.0%)
Ethnicity
    Jaintia 13 (6.5%) 16 (8.0%) 29 (7.3%)
    Khasi 177 (88.5%) 179 (89.5%) 356 (89.0%)
    Others 10 (5.0%) 5 (2.5%) 15 (3.8%)
Religion
    Christian 175 (87.5%) 187 (93.5%) 362 (90.5%)
    Niam Khasi 15 (7.5%) 12 (6.0%) 27 (6.8%)
    Others 10 (5.0%) 1 (0.5%) 11 (2.8%)
Occupation
    Farmer/ Agricultural worker 9 (4.5%) 0 (0%) 9 (2.3%)
    Government Employee* 31 (15.5%) 0 (0%) 31 (7.8%)
    Headmen 14 (7.0%) 0 (0%) 14 (3.5%)
    Homemaker 45 (22.5%) 0 (0%) 45 (11.3%)
    Others 69 (34.5%) 0 (0%) 69 (17.3%)
    Private Business 32 (16.0%) 0 (0%) 32 (8.0%)
    Doctor 0 (0%) 9 (4.5%) 9 (2.3%)
    Frontline health worker 0 (0%) 28 (14.0%) 28 (7.0%)
    Nurse 0 (0%) 81 (40.5%) 81 (20.3%)
    Paramedical Staff 0 (0%) 33 (16.5%) 33 (8.3%)
    Support Staff 0 (0%) 49 (24.5%) 49 (12.3%)
Education
    0 to primary 47 (23.5%) 0 (0%) 47 (11.8%)
    Up to class 7 28 (14.0%) 16 (8.0%) 44 (11.0%)
    Up to class 10 41 (20.5%) 0 (0%) 41 (10.3%)
    Up to class 12 32 (16.0%) 65 (32.5%) 97 (24.3%)
    College degree/Diploma 52 (26.0%) 102 (51.0%) 154 (38.5%)
    Postgraduate 0 (0%) 17 (8.5%) 17 (4.3%)
Received COVID-19 vaccine after April 15
    No 118 (59.0%) 0 (0%) 118 (29.5%)
    Yes 68 (34.0%) 4 (2.0%) 72 (18.0%)
    Response not provided 14 (7.0%) 196 (98.0%) 210 (52.5%)
Currently have children Aged 0–5 years
    No 88 (44.0%) 88 (44.0%) 176 (44.0%)
    Yes 112 (56.0%) 112 (56.0%) 224 (56.0%)
Children received essential immunization
    No 30 (15.0%) 31 (15.5%) 61 (15.3%)
    Yes 82 (41.0%) 81 (40.5%) 163 (40.8%)
    Not applicable 88 (44.0%) 88 (44.0%) 176 (44.0%)
Block of residence
    Mawlai 83 (41.5%) 0 (0%) 83 (20.8%)
    Mawpat 23 (11.5%) 0 (0%) 23 (5.8%)
    Mawryngkneng 19 (9.5%) 0 (0%) 19 (4.8%)
    Mylliem 75 (37.5%) 0 (0%) 75 (18.8%)
    Not asked* 0 (0%) 200 (100%) 200 (50.0%)

* This does not include healthcare workers (HCW) working in the Government sector. HCWs are classified based on their occupational category within the health sector.

Among healthcare workers, breastfeeding was the most common stated reason for COVID-19 vaccine hesitancy (Fig 1A). Other frequently reported reasons included fear of side effects, lack of confidence in the vaccine, a perceived lack of need for the vaccine, and a willingness to wait to be vaccinated. Among community members, the pattern of the most frequently stated keywords was less clear (Fig 1B). However, concerns about side effects and a lack of universal coverage for the vaccine were frequently mentioned by community members.

Fig 1. Word cloud summary of reasons for COVID-19 vaccine hesitancy.

Fig 1

Multiple correspondence analysis

In summary, a total of 105 variable-category combination was reduced to 73 dimensions, explaining 100% of the variance. The top 15 dimensions explained about 51% of the total variance, while the top 5 accounted for 27% of the total variance. The top 15 dimensions and their eigenvalues and the percentage and cumulative percentage of the variance explained were summarized in the supplementary material (Table B in S1 Text). Fig 2 illustrates the coordinate distribution of each variable-category combination on the first two dimensions of the MCA. Results using different dimensions were generated and presented in the supplementary material (Fig A~I in S1 Text).

Fig 2. Coordinates of all the variables on the first two dimensions of multiple correspondence analysis (MCA).

Fig 2

Agglomerative hierarchical clustering

Based on the clustering coefficient and the inertia-based selection criterion, we chose the agglomerative hierarchical clustering algorithm based on Ward’s method to generate 7 unique clusters of vaccine-hesitant participants (Fig 3).

Fig 3. Cluster dendrogram from agglomerative hierarchical clustering analysis (AHCA).

Fig 3

Based on participants’ sociodemographic characteristics (Table C in S1 Text) and reasons for vaccine hesitancy toward COVID-19 vaccines (Fig 4), each cluster was characterized as follows:

Fig 4. Prevalence of negative perceptions of COVID-19 and vaccines by hesitant clusters.

Fig 4

  • Cluster 1 (n = 71): Indecisive healthcare workers

  • Cluster 2 (n = 128): Healthcare workers who do not believe in COVID-19 and COVID-19 vaccine

  • Cluster 3 (n = 14): Highly educated male tribal/clan head with concerns on infertility and/or adverse effect on future pregnancy

  • Cluster 4 (n = 47): Adults with low educational attainment who were highly influenced by influential leaders and family members

  • Cluster 5 (n = 76): Senior adults with worries about COVID-19 vaccine safety

  • Cluster 6 (n = 56): Middle-aged adults with no children aged 0–5 years

  • Cluster 7 (n = 8): Highly educated adults who identified themselves as ethnic and religious minorities with high level of misinformation

Concerns about the cost of the vaccine, despite the fact that vaccines were being provided at no cost to the eligible population, and the complicated online registration process were commonly mentioned barriers to vaccination across all seven clusters. Long distances to vaccination centers were identified as another major barrier to vaccination among community members (clusters 3–7). Healthcare workers were divided into two distinct clusters, and both clusters had a similar distribution of healthcare workers by occupation. The first cluster of healthcare workers had a relatively lower prevalence of COVID-19-related misinformation compared to the other cluster. Their hesitancy seemed to be mainly driven by the difficulties with registration process, combined with opposition from family, peers, and influential leaders, and the concerns about vaccine safety. The second cluster of healthcare workers had a high prevalence of belief that COVID-19 is not a serious illness and that they have developed natural immunity. They were also concerned about vaccine safety and faced logistical challenges in obtaining appointments. Compared to the first cluster of healthcare workers, the second cluster had a notably higher percentage of individuals (>50%) who expressed concern over potential infertility and future pregnancy complications from vaccination. This is consistent with the demographic profile of the healthcare workers in this cluster where the majority were female and of reproductive age. Headmen of tribes or clans had a high prevalence of disbelief in COVID-19 and the majority reported not having any trustworthy source of information for COVID-19 vaccines. They were also more concerned about potential fertility-related side effects of vaccines compared to the other clusters. The fourth cluster consisted of the general population with relatively low prevalence of negative perceptions towards COVID-19 or vaccines. However, similar to the first cluster of healthcare workers, the majority of participants in this group reported being advised against taking the vaccine by influential leaders and family members. The fifth cluster was composed of senior adults who were more concerned about vaccine safety than other groups. They also reported a high prevalence of all COVID-19-related negative perceptions, and reported a willingness to decide on their own which vaccine to take. The sixth cluster consisted of middle-aged adults without children aged 0–5 years, who lacked a trustworthy source for COVID-19-related information. They were advised by family members and influential leaders not to take the vaccine and reported a high willingness to decide on their own which vaccine to take. Over 95% of the individuals in this group, however, reported to have received the vaccine after April 15th, indicating low levels of hesitancy. The seventh and last cluster consisted of highly educated participants who identified themselves as ethnic and religious minorities. They reported being surrounded by high levels of misinformation from various sources, including influential leaders, WhatsApp messages, family members, and friends. This might have led them to believe that COVID-19 was not a serious illness, and COVID-19 vaccines were unsafe.

Discussion

In this study, we used the multiple correspondence analysis in combination with an agglomerative hierarchical clustering analysis to identify distinct groups of vaccine-hesitant individuals among healthcare workers and community members residing in Meghalaya state, India. Within our sample of 400 survey participants, we observed seven distinct clusters. Despite all participants being eligible to receive the COVID-19 vaccine free of charge, the perceived logistical challenges associated with receiving the vaccine were identified as a common barrier contributing to vaccine hesitancy across all seven clusters. These barriers included the long distances between vaccination centers and residences, the perceived cost burden of the vaccine, and the complicated registration process. Similarly, the influence of social networks, including family members, friends, and influential leaders, emerged as an important contributing factor to hesitancy across all the clusters. This is consistent with the findings from two previous studies conducted in Meghalaya, in which social and religious factors were identified as the main drivers of vaccine hesitancy [30,31]. Another study conducted in India also noted that individuals with populistic attitudes towards vaccines tend to be more hesitant towards and resistant to vaccination [41].

Second, the prevalence of COVID-19-related misinformation was high in five of the seven clusters, namely clusters 2, 3, 5, 6, and 7. In these clusters, over 90% of participants believed that COVID-19 was not a serious illness and therefore vaccination was not important. This is particularly noteworthy given that the survey took place at the beginning of the Delta-variant outbreak in the country in May 2021. One possible explanation is that the survey participants were not well-informed about the COVID-19 situation. Concurrently, these same clusters also exhibited very high levels of concern over vaccine safety. The observed trend of heightened vaccine hesitancy could potentially be attributed to the overwhelming prevalence of COVID-19-related misinformation in the country [4143]. Additionally, the specific context in India before and during the survey might have exacerbated the safety concerns with COVID-19 vaccines, including the perceived lack of public transparency from regulatory bodies and the absence of phase 3 trial data of an indigenously-developed vaccine before its roll-out due to expedited approval processes [44,45].

Three clusters–namely, clusters 2, 3, and 5, stood out due to the individuals’ concerns about potential adverse effects of vaccines on fertility and future pregnancy outcomes. Among them, cluster 2 had a high proportion of female healthcare workers of reproductive age, and cluster 3 was mainly characterized as a group of tribal headmen whose marital partners may be of reproductive age. This pattern is consistent with the established knowledge that fertility-related misinformation drives vaccine hesitancy among men and women of reproductive age [46]. Furthermore, female healthcare workers of childbearing age may find themselves at the intersection of heightened exposure to the adverse consequences of COVID-19 and personal concerns regarding vaccine safety and fertility, all of which compounded by societal norms and expectations regarding their professional duty to provide care and their roles within their families, creating a complex decision-making environment regarding vaccination [47,48]. Interestingly, cluster 5, which is comprised of primarily senior participants with more than half aged 60 years or older, also exhibited high levels of concern about vaccine safety and misinformation based on their responses to the 19 questions, potentially explaining the observed higher prevalence of misinformation on infertility and adverse pregnancy-related outcomes among this group. While more information is needed to understand this better, limited access to accurate information, lower educational attainment, generational differences in health beliefs, and potential cognitive factors associated with aging may be contributing factors to this age group’s susceptibility to vaccine-related misinformation. Finally, cluster 7 consisted of a small group of individuals belonging to ethnic and religious minorities in Meghalaya state. Several studies conducted in the United States and the United Kingdom have indicated that ethnic and religious minority groups tend to report higher levels of vaccine hesitancy, often attributed to their lack of trust in local government authorities [4951]. This is particularly important, as it highlights the need to consider such groups in local- and state-level policies and programs to achieve a more equitable distribution of COVID-19 vaccines and ensure that the health benefits of vaccines accrue to all segments of the society.

Our study findings provide valuable insights for local and state health authorities to effectively target distinct subgroups of vaccine-hesitant populations with tailored health messaging. However, it is important to note that our study has a number of limitations. First, we did not explore the prevalence of COVID-19 vaccine hesitancy in the study setting or across the identified clusters of vaccine-hesitant individuals. While the full potential of our study can be better realized if our findings are complemented by this additional information, the lack of data that is representative of the population in Meghalaya state and the scarcity of resources limited the scale of the survey. Second, the use of telephonic interviews, necessitated by pandemic-related restrictions, may have introduced limitations, such as sampling bias, response bias stemming from communication without visual context, and limited understanding of non-verbal cues. Nonetheless, we believe that these biases were minimized by the use of a structured questionnaire in our study. Lastly, our dichotomous survey format, comprising 19 questions probing participants’ reasons for vaccine hesitancy, might have oversimplified the nuanced nature of vaccine hesitancy. The use of validated survey instruments with reliable scales designed to measure the multifaceted aspects of COVID-19 vaccine hesitancy could address this limitation and enhance the generalizability of our findings. Currently, there are validated scales that measure COVID-19 vaccine hesitancy [52,53], which would have allowed us to measure hesitancy in our target population and compare it with that of other studies. A qualitative analysis for an in-depth investigation of the emerging patterns in this study may significantly enrich our understanding of vaccine hesitancy in this population.

Prior to this study, only two other studies have examined the nature of COVID-19 vaccine hesitancy in Meghalaya state, both of which were limited in scope with a specific focus on tribal communities [30,31]. Being the first study to investigate COVID-19 vaccine hesitancy in healthcare and community settings, despite its limitations, this study represents a significant step toward understanding the reasons behind vaccine hesitancy among various subgroups in an area with low overall vaccination rates. Since our study was conducted in May 2021, it is worth noting that Meghalaya state continued to expand vaccine eligibility and coverage over the subsequent year, eventually providing at least one dose of the vaccine to all eligible populations. Nevertheless, achieving full vaccination with two doses for all remained a challenge, with various contributing factors, including vaccine hesitancy, logistical challenges, and reduced communication on the risks of COVID-19.

In this context, our findings remain relevant for local health authorities and highlight both common and distinct factors that shape vaccine hesitancy across different subgroups, calling for a tailored approach to counter it. Potential measures include technology-based health literacy interventions and mass media engagement for social mobilization along with broader health policy measures such as monetary incentives to encourage vaccination that may effectively address the distinct drivers of vaccine hesitancy in various subgroups [54]. Furthermore, our approaches and findings may inform future responses to disease outbreaks that require timely mass population vaccination campaigns, underscoring the importance of targeted and evidence-based community engagement strategies that consider the multifaceted nature of vaccine hesitancy.

Supporting information

S1 Checklist. PLOS inclusivity in global research questionnaire.

(DOCX)

pgph.0002250.s001.docx (68.1KB, docx)
S1 Text

Table A. Vaccine hesitancy questionnaire Table B. Eigen value and percentage of variance explained by each dimension in the multiple correspondence analysis Fig A. Variable coordinates of multiple correspondence analysis (Dimensions 1 and 3) Fig B. Variable coordinates of multiple correspondence analysis (Dimensions 1 and 4) Fig C. Variable coordinates of multiple correspondence analysis (Dimensions 1 and 5) Fig D. Variable coordinates of multiple correspondence analysis (Dimensions 2 and 3) Fig E. Variable coordinates of multiple correspondence analysis (Dimensions 2 and 4) Fig F. Variable coordinates of multiple correspondence analysis (Dimensions 2 and 5) Fig G. Variable coordinates of multiple correspondence analysis (Dimensions 3 and 4) Fig H. Variable coordinates of multiple correspondence analysis (Dimensions 3 and 5) Fig I. Variable coordinates of multiple correspondence analysis (Dimensions 4 and 5) Table C. Demographic and socioeconomic characteristics of survey respondents in each cluster

(DOCX)

pgph.0002250.s002.docx (3.6MB, docx)
S1 Data

(CSV)

pgph.0002250.s003.csv (77.9KB, csv)

Acknowledgments

We would like to express our gratitude to all the volunteers, Phiban Lyngdoh, Olivia Mazumder, Carmenia Khongwir, Peter J. Marbaniang, Carinthia B. Nengnong, Mattimi Passah, Quinnie Dorren Nongrum, Fellicita Pohsnem, Mary M. Rynjah, Alman Kshiar, Baiaineh Nongbri, Baiaineh Nongbri, Vicky Nelson Syiem, Fourness Lamin Amdep, Redolen Rose Dhar, Thangmaism Bikram Singha and Innangkyntiew Lyngdoh for their contribution to the data collection and entry process for this study.

Data Availability

The data that support the findings of this study are available on request from the Indian Institute of Public Health Shillong. Contact information: Indian Institute of Public Health Shillong, Lawmali, Pasteur Hill, Shillong, Meghalaya, India - 793001 Tel: 0364 2592014 Email: iiphs.iec.ner@gmail.com.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.World Health Organization. Impact of COVID-19 on people’s livelihoods, their health and our food systems. 2020. October 13, 2020. Available from: https://www.who.int/news/item/13-10-2020-impact-of-covid-19-on-people’s-livelihoods-their-health-and-our-food-systems. [Google Scholar]
  • 2.Co-WIN: Winning Over COVID-19 [Internet]. [cited April 4, 2023]. Available from: https://dashboard.cowin.gov.in/. [Google Scholar]
  • 3.India [Internet]. 2023. [cited April 4, 2023]. Available from: https://covid19.who.int/region/searo/country/in. [Google Scholar]
  • 4.Wikipedia contributors. COVID-19 vaccination in India 2023. [updated March 12, 2023, https://en.wikipedia.org/w/index.php?title=COVID-19_vaccination_in_India&oldid=1144139311April5,2023]. Available from: https://en.wikipedia.org/w/index.php?title=COVID-19_vaccination_in_India&oldid=1144139311. [Google Scholar]
  • 5.Rackimuthu S, Hasan MM, Bardhan M, Essar MY. COVID-19 vaccination strategies and policies in India: The need for further re-evaluation is a pressing priority. Int J Health Plann Manage. 2022;37(3):1847–50. Epub 2021/09/13. doi: 10.1002/hpm.3321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Pandey A, Sah P, Moghadas SM, Mandal S, Banerjee S, Hotez PJ, et al. Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout. J Glob Health. 2021;11:03083. Epub 2021/07/06. doi: 10.7189/jogh.11.03083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wani MA, Farooq J, Wani DM. Risk assessment of COVID-19 pandemic using deep learning model for J&K in India: a district level analysis. Environ Sci Pollut Res Int. 2022;29(12):18271–81. Epub 2021/10/24. doi: 10.1007/s11356-021-17046-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Basu P, Mazumder R. Regional disparity of covid-19 infections: an investigation using state-level Indian data. Indian Econ Rev. 2021;56(1):215–32. Epub 2021/06/03. doi: 10.1007/s41775-021-00113-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sarkar A, Chouhan P. COVID-19: District level vulnerability assessment in India. Clinical Epidemiology and Global Health. 2021;9:204–15. doi: 10.1016/j.cegh.2020.08.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Co-WIN dashboard [Internet]. 2023. [cited March 24, 2023]. Available from: https://dashboard.cowin.gov.in/. [Google Scholar]
  • 11.Vasudevan V, Gnanasekaran A, Sankar V, Vasudevan SA, Zou J. Disparity in the quality of COVID-19 data reporting across India. BMC Public Health. 2021;21(1):1211. doi: 10.1186/s12889-021-11054-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Al Dahdah M, Guérin I, Ferry M, Venkatasubramanian G. The Covid-19 Crisis in India: A Nascent Humanitarian Tragedy. Comptes rendus de l’Académie des sciences La vie des sciences. 2020. Available from: https://laviedesidees.fr/The-Covid-19-Crisis-in-India [Google Scholar]
  • 13.Mehrotra N, Saaliq S. Vaccine inequality in India sends many falling through gaps. AP News. 2021. May 26, 2021. Available from: https://apnews.com/article/india-technology-coronavirus-pandemic-business-health-9fc262598b4a6e1fc5ff223fdd748cea. [Google Scholar]
  • 14.India Population Census. Meghalaya Population | Sex Ratio | Literacy India 2011. [cited 2023]. Available from: https://www.census2011.co.in/census/state/meghalaya.html#:~:text=Total%20population%20of%20Meghalaya%20as,1%2C176%2C087%20while%20females%20were%201%2C142%2C735. [Google Scholar]
  • 15.Haokip T. Inter-ethnic relations in Meghalaya. Asian Ethnicity. 2014;15(3):302–16. [Google Scholar]
  • 16.Aayog NITI. India National Multidimensional Poverty Index: A Progress Review 2023 2023. Available from: https://niti.gov.in/sites/default/files/2023-08/India-National-Multidimentional-Poverty-Index-2023.pdf. [Google Scholar]
  • 17.India Ministry of Health and Family Welfare. State Fact Sheet: Meghalaya. 2021. [Google Scholar]
  • 18.Kumar S, Sahu A, Kanwar SR. Mobilizing Action to Address Low Child Immunization through Problem Driven Iterative Adaptation (PDIA) Approach: A Case Study of Meghalaya Occasional Paper Series: Section on International and Comparataive Administration 2022. p. 30–44. [Google Scholar]
  • 19.MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34):4161–4. Epub 2015/04/22. doi: 10.1016/j.vaccine.2015.04.036 [DOI] [PubMed] [Google Scholar]
  • 20.Ashok N, Krishnamurthy K, Singh K, Rahman S, Majumder MAA. High COVID-19 vaccine hesitancy among healthcare workers: should such a trend require closer attention by policymakers? Cureus. 2021;13(9). doi: 10.7759/cureus.17990 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Heyerdahl LW, Dielen S, Nguyen T, Van Riet C, Kattumana T, Simas C, et al. Doubt at the core: Unspoken vaccine hesitancy among healthcare workers. The Lancet Regional Health–Europe. 2022;12. doi: 10.1016/j.lanepe.2021.100289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Karafillakis E, Dinca I, Apfel F, Cecconi S, Wűrz A, Takacs J, et al. Vaccine hesitancy among healthcare workers in Europe: A qualitative study. Vaccine. 2016;34(41):5013–20. doi: 10.1016/j.vaccine.2016.08.029 [DOI] [PubMed] [Google Scholar]
  • 23.Paris C, Bénézit F, Geslin M, Polard E, Baldeyrou M, Turmel V, et al. COVID-19 vaccine hesitancy among healthcare workers. Infectious diseases now. 2021;51(5):484–7. doi: 10.1016/j.idnow.2021.04.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Peterson CJ, Lee B, Nugent K. COVID-19 vaccination hesitancy among healthcare workers—a review. Vaccines. 2022;10(6):948. doi: 10.3390/vaccines10060948 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Dubé E. Addressing vaccine hesitancy: the crucial role of healthcare providers. Clinical Microbiology and Infection. 2017;23(5):279–80. doi: 10.1016/j.cmi.2016.11.007 [DOI] [PubMed] [Google Scholar]
  • 26.Sarkar P, Chandrasekaran V, Gunasekaran D, Chinnakali P. COVID-19 vaccine hesitancy among health care worker-parents (HCWP) in Puducherry, India and its implications on their children: A cross sectional descriptive study. Vaccine. 2022;40(40):5821–7. doi: 10.1016/j.vaccine.2022.08.051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Peretti-Watel P, Larson HJ, Ward JK, Schulz WS, Verger P. Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS Curr. 2015;7. Epub 2015/03/20. doi: 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Xiao X, Wong RM. Vaccine hesitancy and perceived behavioral control: A meta-analysis. Vaccine. 2020;38(33):5131–8. doi: 10.1016/j.vaccine.2020.04.076 [DOI] [PubMed] [Google Scholar]
  • 29.Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing Vaccination: Putting Psychological Science Into Action. Psychol Sci Public Interest. 2017;18(3):149–207. Epub 2018/04/04. doi: 10.1177/1529100618760521 [DOI] [PubMed] [Google Scholar]
  • 30.Vasudevan S, Singh S, Newar N, AB A. Perception on Covid-19 vaccinations among tribal communities in East Khasi Hills in Meghalaya. Int J Sci and Med Res. 2021;1(2):1–9. [Google Scholar]
  • 31.Sundaram SP, Ningombam JD, Lyngdoh M, Medhi GK, Lynrah W. Vaccine hesitancy and factors related to vaccine hesitancy in COVID vaccination among a tribal community of Meghalaya: A mixed methods study. Research Square [Preprint]; 2023. Available from: https://europepmc.org/article/PPR/PPR620882. doi: 10.21203/rs.3.rs-2615756/v1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.India Ministry of Health and Family Welfare. ASHA. [April 14, 2023]. Available from: https://web.archive.org/web/20090422204352/ http://mohfw.nic.in/NRHM/asha.htm. [Google Scholar]
  • 33.Fellows I, Fellows MI, Rcpp L, Rcpp L. Package ‘wordcloud’. R package version. 2018;2:331. [Google Scholar]
  • 34.Greenacre M, Blasius J. Multiple Correspondence Analysis and Related Methods: CRC Press; 2006. Available from: https://books.google.com/books?id=uAXOBQAAQBAJ [Google Scholar]
  • 35.Köhn HF, Hubert LJ. Hierarchical cluster analysis. Wiley StatsRef: statistics reference online. 2014:1–13. [Google Scholar]
  • 36.Husson F, Josse J, Pages J. Principal component methods-hierarchical clustering-partitional clustering: why would we need to choose for visualizing data. Applied Mathematics Department. 2010;17. [Google Scholar]
  • 37.Lê S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. Journal of statistical software. 2008;25:1–18. [Google Scholar]
  • 38.Husson F, Josse J, Le S, Mazet J, Husson MF. Package ‘factominer’. An R package. 2016;96:698. [Google Scholar]
  • 39.Kassambara A, Mundt F. Package ‘factoextra’. Extract and visualize the results of multivariate data analyses. 2017;76(2). [Google Scholar]
  • 40.Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K, Studer M, et al. Package ‘cluster’. Dosegljivo na. 2013. [Google Scholar]
  • 41.Umakanthan S, Patil S, Subramaniam N, Sharma R. COVID-19 Vaccine Hesitancy and Resistance in India Explored through a Population-Based Longitudinal Survey. Vaccines (Basel). 2021;9(10). Epub 2021/10/27. doi: 10.3390/vaccines9101064 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 42.Kanozia R, Arya R. “Fake news”, religion, and COVID-19 vaccine hesitancy in India, Pakistan, and Bangladesh. Media Asia. 2021;48(4):313–21. [Google Scholar]
  • 43.Rameneni T, Sayeed T, Kumar S. A Perspective On COVID-19 Vaccine Hesitancy in India. National Journal of Community Medicine. 2022;13(07):491–3. [Google Scholar]
  • 44.Das KN. Pfizer says it told India there no safety concern with its COVID-19 vaccine. Reuters. 2021. [Google Scholar]
  • 45.Sarkar MA, Ozair A, Singh KK, Subash NR, Bardhan M, Khulbe Y. SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health. Ann Glob Health. 2021;87(1):124. Epub 2021/12/30. doi: 10.5334/aogh.3530 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Hsu AL, Johnson T, Phillips L, Nelson TB. Sources of Vaccine Hesitancy: Pregnancy, Infertility, Minority Concerns, and General Skepticism. Open Forum Infectious Diseases. 2021;9(3). doi: 10.1093/ofid/ofab433 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Krishnan S. Exploring female frontline health workers’ role and capacities in COVID-19 response in India. International Journal of Disaster Risk Reduction. 2022;75:102962. doi: 10.1016/j.ijdrr.2022.102962 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Chatterjee SS, Chakrabarty M, Banerjee D, Grover S, Chatterjee SS, Dan U. Stress, Sleep and Psychological Impact in Healthcare Workers During the Early Phase of COVID-19 in India: A Factor Analysis. Front Psychol. 2021;12:611314. Epub 2021/03/16. doi: 10.3389/fpsyg.2021.611314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Razai MS, Osama T, McKechnie DGJ, Majeed A. Covid-19 vaccine hesitancy among ethnic minority groups. BMJ. 2021;372:n513. Epub 2021/02/28. doi: 10.1136/bmj.n513 [DOI] [PubMed] [Google Scholar]
  • 50.Hussain B, Latif A, Timmons S, Nkhoma K, Nellums LB. Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies. Vaccine. 2022. doi: 10.1016/j.vaccine.2022.04.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Nguyen LH, Joshi AD, Drew DA, Merino J, Ma W, Lo C-H, et al. Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake [Preprint]. medrxiv. 2021. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924296/. doi: 10.1101/2021.02.25.21252402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychological medicine. 2022;52(14):3127–41. doi: 10.1017/S0033291720005188 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kotta I, Kalcza-Janosi K, Szabo K, Marschalko EE. Development and validation of the multidimensional COVID-19 vaccine hesitancy scale. Human vaccines & immunotherapeutics. 2022;18(1):1–10. doi: 10.1080/21645515.2021.2007708 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Singh P, Dhalaria P, Kashyap S, Soni GK, Nandi P, Ghosh S, et al. Strategies to overcome vaccine hesitancy: a systematic review. Systematic Reviews. 2022;11(1):78. doi: 10.1186/s13643-022-01941-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002250.r001

Decision Letter 0

Nnodimele Onuigbo Atulomah

23 Oct 2023

PGPH-D-23-01274

Understanding COVID-19 Vaccine Hesitancy in Meghalaya, India: An Analysis of Cross-Sectional Survey Data Using Multiple Correspondence Analysis and Agglomerative Hierarchical Clustering

PLOS Global Public Health

Dear Dr. Tozan,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

EDITOR'S COMMENTS:

  • Consider the points raised by the reviewers carefully and address them,

  • A suggestion for title revision has been made, I believe that the study will benefit from such revision,

  • Kindly address issues pertaining to how instrument developed for data collection was validated and reliability ensured. 

Please submit your revised manuscript by 10th November 2023. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Nnodimele Onuigbo Atulomah, PhD

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

2. In the ethics statement in the Methods, you have specified that verbal consent was obtained. Please provide additional details regarding how this consent was documented and witnessed, and state whether this was approved by the IRB

3. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/globalpublichealth/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

4. Please send a completed 'Competing Interests' statement, including any COIs declared by your co-authors. If you have no competing interests to declare, please state "The authors have declared that no competing interests exist". Otherwise please declare all competing interests beginning with twhe statement "I have read the journal's policy and the authors of this manuscript have the following competing interests:"

5. Please provide separate figure files in .tif or .eps format only and remove any figures embedded in your manuscript file. Please also ensure all files are under our size limit of 10MB.

For more information about figure files please see our guidelines:

https://journals.plos.org/globalpublichealth/s/figures 

https://journals.plos.org/globalpublichealth/s/figures#loc-file-requirement

6. We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list.

7. In the online submission form, you indicated that "The data that support the findings of this study are available on request from the corresponding author, SA". All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons by return email and your exemption request will be escalated to the editor for approval. Your exemption request will be handled independently and will not hold up the peer review process, but will need to be resolved should your manuscript be accepted for publication. One of the Editorial team will then be in touch if there are any issues.

Additional Editor Comments (if provided):

The manuscript has been reviewed and considered as an important contribution be included in the field to provide some understanding of the emerging challenges associated with Vaccine Hesitancy. However, to make the manuscript acceptable for publication, certain revisions have been suggested. Kindly pay attention to these suggestions as these would strengthen the manuscript more and clarify issues appropriately.

Title: The current title appears too long and needs modification. Suggested modification reads thus: "Elucidating the dynamics involved in COVID-19 Vaccine Hesitancy in Meghalaya, India: An Agglomerative Hierarchical Cluster Analysis".

Introduction: The last two sentences of the introduction mention "...The issue of vaccine hesitancy has become more apparent during a global pandemic and in the face of a new vaccine to address it" What science explains the dynamics involved in vaccine hesitancy? This has not featured in the study theoretical principles. It is expected that vaccine hesitancy is a personal-level disposition that triggers refusal or acceptance. The theoretical framework elucidating the disposition is completely omitted and not considered for evaluation in the study.

Methods: The instrument development process appears missing including methods applied for assuring validity and reliability. The variables measured are not explicitly indicated in the methodology, but somewhere in figure 4 it gives the impression that negative perceptions of COVID-19 were measured. How was perception conceived and operationalized in the methodology of instrument development?

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscripts highlights important factors in the fight against COVID-19, particularly vaccine hesitancy and associated factors. This research is a thorough research that was done and the results well presented. The findings has potentials to impact public health policy and educational as well as health communication program design and implementation.

The objective of the research and manuscript is very clear. A robust statistical analysis procedures were used in analyzing and presenting the findings. Again, the authors have presented a discussion section that relates well with existing limited literature in the COVID-19 research and will had positive impact on knowledge and practices.

I do recommend that the language of the manuscript especially the methods section be examined again and effort needs to be made tp present the methods section with lay person's language and reading level. It appears to be verbose and use of technical terminology are used. This will make it a challenging for the general academic public to understand. Secondly, figures 2 and 4 don't appear clear and readers may not appreciate the importance of the messages in the figures. Please, make the figures more clear and simple to understand.

Overall, the author have presented a very elaborate research design and findings that only informs the Indian authorities and public about the determinants of covid-19 vaccine hesitancy, but the whole world, especially in developing countries where more misinformation, disinformation, and cultural barriers are reported to be challenges of health behavior.

Reviewer #2: Overall, the article is well-structured and informative. However, there are a few areas where improvements could be made for publication.

Title of the study

• It's a bit long and detailed, which might make it less reader-friendly. Consider simplifying it while retaining the essential information.

Abstract

• Ensure that the abstract is concise while retaining clarity. Some sentences, such as those introducing the identified clusters, could be streamlined for brevity without sacrificing essential information.

• Specify the timeframe of the survey administration. Knowing when the survey was conducted is important, especially when dealing with evolving situations like the COVID-19 pandemic.

Background of the study

• The mention of disparities in the quality of COVID-19 data reporting is crucial, but the article could elaborate on how this may impact the understanding of vaccine hesitancy.

• While the authors acknowledge regional disparities in COVID-19 infection and vaccination rates, they could delve deeper into the specific factors contributing to these disparities, beyond stating that they are highly clustered in more urbanized and prosperous states.

• While the study provides valuable insights into vaccine hesitancy, incorporating a theoretical framework would have enhanced the robustness and interpretability of the findings by offering a structured lens through which to analyze and understand the complex factors influencing vaccine hesitancy in diverse subpopulations.

Method

• The study period is mentioned as May 2021, but the recruitment of participants is stated as May 1st, 2022, to May 22th, 2022. There seems to be a discrepancy; please clarify the correct dates for the study period and recruitment.

• It would be helpful to provide information on the sample size determination process and power analysis to ensure that the study has sufficient statistical power to detect meaningful differences within subgroups.

• While telephonic interviews were necessary due to pandemic-related restrictions, acknowledge and discuss potential limitations introduced by this mode of data collection.

• The dichotomous (yes or no) response format for the 19 questions might oversimplify the complexity of vaccine hesitancy.

• While verbal consent is mentioned, it would be beneficial to elaborate on the specifics of the consent process, ensuring participants fully understand the purpose of the study, their rights, and the potential implications of their participation.

• While you've described the methods used in data analysis (e.g., agglomerative hierarchical clustering based on Ward’s method), providing a brief rationale or justification for choosing these methods would add depth to the paper. This could help readers understand why these specific analytical approaches were employed.

Results

• It might be helpful to use subheadings to distinguish between different sections of the results, making it easier for readers to follow the flow of information.

• For each cluster, provide more context on why certain characteristics or attitudes are prevalent within that group. This could involve a deeper exploration of the socio-cultural context in Meghalaya that may contribute to these patterns of vaccine hesitancy.

• Use consistent terminology throughout the paper. For example, ensure that terms like "undecisive" are used consistently, and consider alternatives such as "indecisive" for clarity.

Discussion of Findings and Addressing Study Limitations

• Explore further the gender and age dynamics within clusters, especially Cluster 2 with female healthcare workers and Cluster 5 with senior participants. Provide insights into how age and gender intersect with vaccine hesitancy.

• Given that the study was conducted in May 2021, consider discussing the relevance and timeliness of the findings in the context of the evolving COVID-19 situation. This is particularly important if there have been significant changes in vaccine distribution, public perception, or policies since the study period.

• Acknowledge the study's limitations, such as the lack of data representative of the entire population in Meghalaya and the use of non-validated survey instruments. Discuss how these limitations might affect the generalizability of the findings.

Proposing Future Research Directions:

• Suggest potential avenues for future research based on the gaps identified in this study.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0002250.r003

Decision Letter 1

Nnodimele Onuigbo Atulomah

29 Jan 2024

Understanding COVID-19 Vaccine Hesitancy in Meghalaya, India: Multiple Correspondence and Agglomerative Hierarchical Cluster Analyses

PGPH-D-23-01274R1

Dear Dr. Tozan,

We are pleased to inform you that your manuscript 'Understanding COVID-19 Vaccine Hesitancy in Meghalaya, India: Multiple Correspondence and Agglomerative Hierarchical Cluster Analyses' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Nnodimele Onuigbo Atulomah, PhD

Academic Editor

PLOS Global Public Health

***********************************************************

The reviewers' recommendations have all been performed successfully to the satisfaction of the academic editor.

Reviewer Comments (if any, and for reference):

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. PLOS inclusivity in global research questionnaire.

    (DOCX)

    pgph.0002250.s001.docx (68.1KB, docx)
    S1 Text

    Table A. Vaccine hesitancy questionnaire Table B. Eigen value and percentage of variance explained by each dimension in the multiple correspondence analysis Fig A. Variable coordinates of multiple correspondence analysis (Dimensions 1 and 3) Fig B. Variable coordinates of multiple correspondence analysis (Dimensions 1 and 4) Fig C. Variable coordinates of multiple correspondence analysis (Dimensions 1 and 5) Fig D. Variable coordinates of multiple correspondence analysis (Dimensions 2 and 3) Fig E. Variable coordinates of multiple correspondence analysis (Dimensions 2 and 4) Fig F. Variable coordinates of multiple correspondence analysis (Dimensions 2 and 5) Fig G. Variable coordinates of multiple correspondence analysis (Dimensions 3 and 4) Fig H. Variable coordinates of multiple correspondence analysis (Dimensions 3 and 5) Fig I. Variable coordinates of multiple correspondence analysis (Dimensions 4 and 5) Table C. Demographic and socioeconomic characteristics of survey respondents in each cluster

    (DOCX)

    pgph.0002250.s002.docx (3.6MB, docx)
    S1 Data

    (CSV)

    pgph.0002250.s003.csv (77.9KB, csv)
    Attachment

    Submitted filename: Megh_Response to editor and reviewers_final.docx

    pgph.0002250.s004.docx (24.8KB, docx)

    Data Availability Statement

    The data that support the findings of this study are available on request from the Indian Institute of Public Health Shillong. Contact information: Indian Institute of Public Health Shillong, Lawmali, Pasteur Hill, Shillong, Meghalaya, India - 793001 Tel: 0364 2592014 Email: iiphs.iec.ner@gmail.com.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES